Since ClpP activators, but not ClpP inhibitors, show cytotoxicity in breast cancers, we will focus on ClpP activators in this review (for ClpP inhibitors, we refer readers to other excellent reviews [233,264,266]. This evidence concerns the gene CLPP and breast cancer.